摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-carbamoyloxyethyl methacrylate | 24345-44-6

中文名称
——
中文别名
——
英文名称
2-carbamoyloxyethyl methacrylate
英文别名
2-Propenoic acid, 2-methyl-, 2-[(aminocarbonyl)oxy]ethyl ester;2-carbamoyloxyethyl 2-methylprop-2-enoate
2-carbamoyloxyethyl methacrylate化学式
CAS
24345-44-6
化学式
C7H11NO4
mdl
——
分子量
173.169
InChiKey
GZEXHGDBYMTBCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    78.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    2-羟基乙基氨基甲酸酯甲基丙烯酸酐2,6-二叔丁基-4-甲基苯酚1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 反应 4.0h, 以61%的产率得到2-carbamoyloxyethyl methacrylate
    参考文献:
    名称:
    [DE] VERFAHREN ZUR HERSTELLUNG VON CARBAMATGRUPPEN UMFASSENDEN (METH)ACRYLSÄUREESTERN
    [EN] METHOD FOR PRODUCING CARBAMATE GROUP-CONTAINING (METH)ACRYLIC ESTERS
    [FR] PROCEDE DE PRODUCTION D'ESTERS D'ACIDE (METH)ACRYLIQUE CONTENANT DES GROUPES CARBAMATE
    摘要:
    这项发明涉及制备含有氨基甲酸酯基的(甲基)丙烯酸酯的方法,其中至少一种含有氨基甲酸酯基的羟基化合物与(甲基)丙烯酸酐在至少一种抑制剂和至少一种酸性催化剂的存在下反应。通过该方法,可以获得高纯度的所需产品。
    公开号:
    WO2005047234A1
点击查看最新优质反应信息

文献信息

  • CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS
    申请人:Trujillo-Lemon Marianela
    公开号:US20100307378A1
    公开(公告)日:2010-12-09
    The present invention relates, generally, to monomers containing carbamate-methacrylates or derivatives of carbamate-methacrylates, processes for making the monomers, and compositions comprising the monomers. The present invention also relates to methods of using the monomers, such as in dental applications, and in particular, dental restorative resins.
    本发明涉及含有碳酸酯-甲基丙烯酸酯或碳酸酯-甲基丙烯酸酯衍生物的单体,制备该单体的方法以及包含该单体的组合物。本发明还涉及使用该单体的方法,例如在牙科应用中,特别是在牙科修复树脂中的应用。
  • Silicon-containing compound and ocular lens material
    申请人:Menicon Co., Ltd.
    公开号:EP0781777A1
    公开(公告)日:1997-07-02
    A silicon-containing compound of the formula (I): wherein R1 is a C1-6 alkylene group; A is a group of the formula (II): wherein R2 is a hydrogen atom or a methyl group, R3 is a C1-6 trivalent hydrocarbon group or a C1-6 bivalent hydrocarbon group when R4 is a hydrogen atom, and R4 is a hydrogen atom, a hydroxyl group, a C1-6 alkyl group or a group of the formula (III): wherein R5 is a C1-6 alkylene group, and m is an integer of from 1 to 15, or a group of the formula (IV): wherein R6 is a hydrogen atom or a methyl group, and R7 is a direct bond or a C1-6 alkylene group; and n is an integer of from 1 to 15.
    化合物的化学式为(I):其中R1是C1-6烷基;A是化学式(II)的基团:其中R2是氢原子或甲基基团,R3是C1-6三价碳氢基团或C1-6二价碳氢基团(当R4是氢原子时),而R4是氢原子、羟基、C1-6烷基或化学式(III)的基团:其中R5是C1-6烷基,m是1至15的整数,或化学式(IV)的基团:其中R6是氢原子或甲基基团,R7是直接键或C1-6烷基,n是1至15的整数。
  • Thermosetting compositions containing alternating copolymers of isobutylene type monomers
    申请人:——
    公开号:US20030171497A1
    公开(公告)日:2003-09-11
    A thermosetting composition that includes an ungelled copolymer composition and a crosslinking agent. The ungelled copolymer composition includes a functional group-containing copolymer that includes segments of alternating residues derived from a donor monomer composition comprising an acceptor monomer composition. The donor monomer composition includes one or both of isobutylene and diisobutylene, and the acceptor monomer composition includes acrylic monomers and monomers containing functional groups. The ungelled copolymer composition is substantially free of transition metals and Lewis acids, and the copolymer is substantially free of maleate-type monomer residues and fumarate-type monomer residues. The crosslinking agent has at least two functional groups that are reactive with the functional groups of the copolymer. The thermosetting composition may be in liquid, powder, or dispersed form and may be applied by traditional or electrocoating methods.
    一种热固性组合物,包括未胶凝的共聚物组合物和交联剂。未胶凝的共聚物组合物包括一个含有功能性基团的共聚物,其中包括从给体单体组成中得到的交替残基段,该给体单体组成包括受体单体组成。给体单体组成包括异丁烯和二异丁烯中的至少一种,而受体单体组成包括丙烯酸单体和含有功能性基团的单体。未胶凝的共聚物组合物基本上不含过渡属和路易斯酸,而共聚物基本上不含马来酸型单体残基和富马酸型单体残基。交联剂具有至少两个与共聚物的功能性基团反应的功能性基团。热固性组合物可以是液体、粉末或分散形式,并且可以通过传统或电泳涂覆方法应用。
  • Light emitting material and organic light-emitting device
    申请人:——
    公开号:US20040247934A1
    公开(公告)日:2004-12-09
    A polymer light emitting material, wherein the material has a light emitting mechanism based on transition from an excited triplet state to a ground state or transition through an excited triplet state to a ground state of an electron energy level, and the material comprises a nonionic light emitting part which constitutes a part of the polymer or is bound to the polymer. The polymer light emitting material exhibits high light emission efficiency above 5%, which is the limit of external quantum efficiency of fluorescence and can be designed so as to have a large area and hence are suitable for mass production of organic light emitting devices.
    一种聚合物发光材料,该材料具有基于从激发的三重态到基态的跃迁或通过激发的三重态到电子能级基态的跃迁的发光机制,并且该材料包括构成聚合物一部分或与聚合物结合的非离子发光部分。该聚合物发光材料表现出高于5%的高发光效率,这是荧光外部量子效率的极限,并且可以设计成具有大面积,因此适合大规模生产有机发光器件。
  • IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE
    申请人:Igarashi Takeshi
    公开号:US20090315454A1
    公开(公告)日:2009-12-24
    The present invention provides an organic EL device having a high luminous efficiency and a long life, and an iridium complex compound used for preparing the above device. The iridium complex compound is represented by the following Formula (1): [in Formula (1), R 1 to R 4 are each independently a specific group; at least one of R 1 to R 4 is a group having 2 or more carbon atoms; R 5 to R 8 are each independently a specific group; and at least one of R 5 to R 8 is a specific electron-withdrawing group; (with the proviso that R 1 to R 8 are not combined with each other to form rings)].
    本发明提供了一种具有高发光效率和长寿命的有机EL器件,以及用于制备上述器件的配合物化合物。配合物化合物由以下公式(1)表示:[在公式(1)中,R1至R4各自独立地表示特定的基团;至少有一个R1至R4是具有2个或更多碳原子的基团;R5至R8各自独立地表示特定的基团;并且至少有一个R5至R8是特定的电子吸引基团;(前提是R1至R8不与彼此结合形成环)]。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸